Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Steven Muntner

New York, NY
Steven Muntner is Vice President in charge of deals for Informa Pharma including Strategic Transactions and Medtrack.  In this role, he oversees all of the healthcare deals content spanning partnerships, mergers and acquisitions, and public and private financings for pharmaceutical, biotech, diagnostic and medical device companies.  Prior to this role, Mr. Muntner was an analyst with Medtrack and Strategic Transactions and joined Informa in the beginning of 2013.  Mr. Muntner is a published author, having written content for Nature Biotech and the Wall Street Journal.  Before his tenure at Informa, Mr. Muntner worked across the financial services industry in healthcare investment banking, with several years of experience at Natixis and Ladenburg Thalmann.  He graduated with a bachelors in business administration from Emory University in Atlanta, Georgia.  

Latest From Steven Muntner

Deals Shaping The Medical Industry, February 2019

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the deal-making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in January 2019.

BioPharmaceutical Medical Device

Deals Shaping The Medical Industry, January 2019

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in December 2018.

Deals Market Intelligence

Deals Shaping The Medical Industry, September 2018

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in August 2018.

Deals BioPharmaceutical

Deals Shaping The Medical Industry, May 2018

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in April 2018.

Deals Market Intelligence

Deals Shaping The Medical Industry April 2018

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in March 2018. 

Deals BioPharmaceutical

Deals Shaping The Medical Industry, March 2018

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in February 2018.  

Deals BioPharmaceutical
See All
UsernamePublicRestriction

Register